Screening Young Adults for Loneliness: What the Evidence Actually Supports

The Surgeon General’s 2023 advisory calls for health systems to treat social connection as something clinicians routinely assess, alongside blood pressure and smoking status. That recommendation did not appear from nowhere. It builds on a specific precedent: the National Academies of Sciences, Engineering, and Medicine’s 2020 consensus report, which concluded that roughly one quarter of adults aged 65 and older are socially isolated and recommended that health care systems assess for isolation and loneliness in that population as a matter of course.

The advisory extends that logic across the age range. The question worth asking is whether the evidence behind it was ever built to support that extension.

The evidence base is an older-adult evidence base

The National Academies report’s recommendation rests on a body of work developed largely in midlife and older cohorts. The American Heart Association’s 2022 scientific statement on social isolation, cardiovascular disease, and brain health draws its 29% increased risk of heart attack or death from heart disease, and its 32% increased risk of stroke, from studies whose populations skew toward the ages at which cardiovascular events actually occur. The statement’s authors are explicit about a gap: the association evidence is substantial, but evidence that any intervention reduces those risks by reducing isolation is close to absent. That gap matters for anyone extending the recommendation, because it means the clinical case for screening older adults already rests more on epidemiological association than on demonstrated benefit from acting on a positive screen.

Extend that same recommendation to a 22-year-old, and the mismatch compounds. The outcome that motivated the original recommendation — cardiovascular events, stroke, dementia-adjacent cognitive decline — is rare in young adulthood regardless of social connection. A screening tool justified by its ability to flag elevated mortality risk in a 70-year-old is being asked to justify itself on different grounds in a 25-year-old, where the near-term health consequences of loneliness, if any, look different and are less studied.

Prevalence is higher in young adults, which is not the same as risk being better understood

None of this means young adults are less lonely. The opposite is true by most available measures. Harvard’s Making Caring Common project found 61% of adults aged 18 to 25 reporting serious loneliness in 2021, against 36% of Americans overall — the highest rate of any age group surveyed. Cigna’s 2020 loneliness index found 73% of workers aged 18 to 22 reporting loneliness. Gallup’s 2023 global survey found the same age skew outside the United States: adults aged 19 to 29 reported loneliness at 27%, against 17% among adults 65 and older, the lowest rate of any age band measured.

That inversion — young adults report more loneliness, older adults face better-documented downstream health consequences — is the crux of the problem. Julianne Holt-Lunstad’s 2015 meta-analysis in Perspectives on Psychological Science found that social isolation and loneliness were, if anything, more predictive of early mortality in samples averaging under 65 than in older samples. That is a genuinely important finding, and it argues against treating loneliness as primarily a late-life clinical concern. But it is one meta-analytic finding about mortality risk pooled across studies, not a demonstration that a screening instrument administered in a young-adult clinical setting identifies people who benefit from a specific intervention. Risk and actionable screening are not the same claim.

What happens after a positive screen

Even where health systems have implemented connection-related screening, largely through social prescribing programs in the UK, the evidence on what follows is thin and not age-stratified. A 2021 systematic review in the International Journal of Environmental Research and Public Health found consistent gains in self-esteem and confidence but noted limited trial evidence and substantial heterogeneity across programs. A separate 2021 systematic review specific to loneliness outcomes found all nine included studies reported positive individual impacts, with three showing reduced use of GP, emergency, or inpatient services — but again, without breaking results out by age. A 2022 qualitative synthesis found that participants valued restored purpose and structured activity more than contact itself, which is a useful design insight but not evidence that a young-adult population, with a different set of social and institutional touchpoints than retirees, would respond the same way to the same referral pathway.

The AARP Foundation’s 2018 survey of adults 45 and older is worth noting for a different reason: it used the 20-item UCLA Loneliness Scale, the same instrument used across much of the academic literature, rather than a bespoke question. That comparability is exactly what is missing when policy documents move across age groups — the instruments, samples, and outcome measures were not built with a common age target in mind, and stitching them together to justify a single clinical protocol obscures how much translation is actually happening.

None of this argues against paying attention to loneliness in young adults, whose rates are the highest of any group measured. It argues that the recommendation to screen for it clinically is currently borrowing its evidentiary authority from a body of research built for a different population and a different outcome. A study that would settle the question would need an age-stratified intervention trial with young-adult participants, a validated instrument used consistently across the sample, and a defined care pathway tested against a specific outcome — not mortality forty years off, but something measurable within the timeframe a clinic could act on.